Susan Pfefferle to Antiviral Agents
This is a "connection" page, showing publications Susan Pfefferle has written about Antiviral Agents.
Connection Strength
0.563
-
Pfefferle S, Sch?pf J, K?gl M, Friedel CC, M?ller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Z?st R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Wessels C, P?hlmann S, Haas J, Drosten C, von Brunn A. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011 Oct; 7(10):e1002331.
Score: 0.296
-
Meister TL, Nocke MK, Heinen N, Burkard TL, Br?ggemann Y, Westhoven S, Tr?eb B, Ebert N, Thomann L, Lubieniecki KP, Lubieniecka JM, D?ring K, Herrmann M, Haid S, Pietschmann T, Wiegmann B, Tao R, Pfefferle S, Addo MM, Thiel V, Drexler I, Babel N, Phuc Nguyen H, Brown RJP, Todt D, Steinmann E, Pfaender S. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants. Proc Natl Acad Sci U S A. 2025 Jul 15; 122(28):e2500276122.
Score: 0.192
-
Struck AW, Axmann M, Pfefferle S, Drosten C, Meyer B. A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. Antiviral Res. 2012 Jun; 94(3):288-96.
Score: 0.075